RPG Life Sciences
add_icon

RPG Life Sciences

2,311.10
-103.10
(-4.27%)
Market Cap
3,822.33 Cr
PE Ratio
34.64
Volume
9,010.00
Day High - Low
2,416.70 - 2,298.90
52W High-Low
2,725.00 - 1,733.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
3,822.33 Cr
EPS
69.64
PE Ratio
34.64
PB Ratio
6.59
Book Value
366.01
EBITDA
147.13
Dividend Yield
0.99 %
Industry
Healthcare
Return on Equity
34.54
Debt to Equity
0.00
Forecast For
Actual

Company News

View All News
Caret
positive
RPG Life Sciences FY26 revenue Rs. 70,752 lakhs, net profit Rs. 11,517 lakhs, Rs. 24 dividend recommended; Q4 FY26 earnings call transcript now available on company website.
positive
RPG Life Sciences reported Q4 FY26 revenue of Rs 176.9 crore, up 23.6% YoY. PAT grew 58.1% to Rs 29.3 crore, EBITDA rose 48% to Rs 45.2 crore with margin at 25.6%. Board recommended Rs 24 dividend.
neutral
RPG Life Sciences submitted certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended March 2026, confirming compliance with dematerialisation requirements.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,845.70
#1 4,42,845.26
41.02
#1 54,729.00
9.71
#1 10,980
16.07
62.53
6,644.00
1,76,377.32
71.90
9,712.00
18.67
2,191
-1.02
66.51
4,381.90
1,48,303.41
67.32
11,539.40
6.99
1,911
26.24
58.68
1,270.00
1,05,999.66
19.34
33,741.20
16.73
5,725
-15.28
48.03
1,292.30
1,04,389.50
23.25
28,409.50
7.12
5,291
-57.18
49.42
2,245.40
1,02,624.48
19.17
27,487.50
19.98
5,345
#1 87.72
41.00
2,378.90
98,202.20
56.53
12,744.20
20.90
2,007
7.65
65.09
930.65
93,645.17
#1 19.15
23,511.00
18.55
4,615
-0.32
52.94
1,488.20
86,434.90
24.77
32,345.60
9.43
3,484
7.59
70.74
1,268.00
68,453.81
76.81
6,812.90
#1 21.03
884
21.18
75.68
Growth Rate
Revenue Growth
6.22 %
Net Income Growth
-34.80 %
Cash Flow Change
-17.49 %
ROE
47.67 %
ROCE
40.14 %
EBITDA Margin (Avg.)
-22.84 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
176
258
166
197
183
190
Expenses
124
118
125
143
149
144
EBITDA
53
140
41
55
35
46
Operating Profit %
28 %
18 %
26 %
21 %
17 %
19 %
Depreciation
6
5
5
5
5
6
Interest
0
0
0
0
0
0
Profit Before Tax
47
135
35
50
29
40
Tax
12
18
9
13
7
10
Net Profit
35
117
26
37
22
30
EPS in ₹
21.12
70.96
15.90
22.28
13.38
18.08

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
197
205
247
291
251
267
303
345
419
513
658
793
Fixed Assets
105
109
137
131
128
123
113
104
124
114
172
220
Current Assets
86
87
96
143
97
126
176
207
264
298
465
525
Capital Work in Progress
1
2
2
9
17
10
12
31
25
96
16
20
Investments
0
0
0
0
0
0
0
0
58
91
127
124
Other Assets
92
94
108
152
106
134
178
210
211
212
343
0
Total Equity & Liabilities
197
205
247
291
251
267
303
345
419
513
658
793
Current Liabilities
67
67
79
121
78
83
80
80
103
131
120
161
Non Current Liabilities
5
5
21
16
13
8
7
9
9
7
7
27
Total Equity
125
134
147
155
161
177
216
256
308
375
531
605
Reserve & Surplus
112
120
134
142
147
163
203
243
294
362
517
592
Share Capital
13
13
13
13
13
13
13
13
13
13
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
1
-1
0
0
40
17
-32
-5
9
Investing Activities
-10
-15
-30
-16
-19
-11
-8
-35
-106
-79
-42
Operating Activities
-2
33
7
15
46
50
58
65
91
94
78
Financing Activities
12
-18
23
0
-27
-39
-11
-14
-17
-20
-27

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
72.07 %
72.07 %
72.07 %
72.07 %
72.07 %
72.41 %
72.61 %
72.61 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.95 %
72.95 %
72.95 %
72.95 %
72.95 %
72.95 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.46 %
0.56 %
0.89 %
1.14 %
1.35 %
1.30 %
1.45 %
1.35 %
1.11 %
1.00 %
0.87 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
2.04 %
2.02 %
2.12 %
2.29 %
3.59 %
3.79 %
4.19 %
4.63 %
5.45 %
6.06 %
6.14 %
6.48 %
6.70 %
7.04 %
7.45 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
20.45 %
20.59 %
20.58 %
20.65 %
20.85 %
20.37 %
19.91 %
20.26 %
19.91 %
19.45 %
18.41 %
18.16 %
17.41 %
16.79 %
15.92 %
15.58 %
15.33 %
15.46 %
15.37 %
15.17 %
14.98 %
Others
7.47 %
7.33 %
7.34 %
7.28 %
7.07 %
7.21 %
5.44 %
5.10 %
5.16 %
5.45 %
4.73 %
4.67 %
4.70 %
4.62 %
4.47 %
4.11 %
4.12 %
3.76 %
3.88 %
3.83 %
3.74 %
No of Share Holders
18,701
20,564
23,674
22,768
22,821
22,115
20,757
21,360
20,837
20,226
21,088
21,866
22,137
22,232
23,481
24,891
24,867
25,832
26,657
25,905
25,282

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 2.8 2.4 2.4 4 7.2 9.6 12 16 24 0.00
Dividend Yield (%) 0.73 0.97 1.41 1.03 1.28 1.4 0.79 0.7 1.29 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
17 Aug 2021 DIVIDEND Dividend
₹ 7.20 /share
13 Aug 2021 490.80 516.85
15 Jul 2022 DIVIDEND Dividend
₹ 9.60 /share
14 Jul 2022 589.35 568.55
21 Jul 2023 DIVIDEND Dividend
₹ 12.00 /share
21 Jul 2023 820.55 996.65
28 Jun 2024 DIVIDEND Dividend
₹ 16.00 /share
28 Jun 2024 1,560.55 1,599.95
16 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
16 Jul 2024 1,535.60 1,640.55
07 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2024 2,443.95 2,673.90
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jan 2025 2,067.10 2,166.65
28 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Apr 2025 2,197.25 2,244.30
27 Jun 2025 DIVIDEND Dividend
₹ 20.00 /share
27 Jun 2025 2,244.30 2,424.10
27 Jun 2025 DIVIDEND Dividend
₹ 4.00 /share
27 Jun 2025 2,244.30 2,424.10
16 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
16 Jul 2025 2,341.50 2,557.00
25 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 Jul 2025 2,548.80 2,515.25
17 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
17 Oct 2025 2,234.25 2,306.00
27 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Jan 2026 2,295.45 2,135.40
29 Apr 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Apr 2026 1,998.70 2,058.75

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeApr 30, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 30, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationApr 30, 2026
Amendment To The CodeApr 29, 2026
Corporate Action-Board to consider DividendApr 29, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementApr 29, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 29, 2026
Financial ResultsApr 29, 2026
Board Meeting Outcome for Outcome Of Board MeetingApr 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 23, 2026
Board Meeting Intimation for The Company Has Informed BSE That The Meeting Of The Board Of Directors Of The Company Is Scheduled On 29Th April 2026 Apr 22, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Apr 20, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 07, 2026
Intimation To Exchange About "Second -100 Days Campaign - Saksham Niveshak"Apr 06, 2026
Closure of Trading WindowMar 24, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 10, 2026
General UpdatesJan 30, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 28, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 28, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 27, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 27, 2026
Financial Result Quarter Ended On December 31 2025Jan 27, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On January 27 2026.Jan 27, 2026
Board Meeting Intimation for Intimation Of Board MeetingJan 20, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 07, 2026
Disclosure Under Regulation 30 Of SEBI LODR 2015 For Details Of Order Received From GST Authority MaharashtraDec 29, 2025
Incorporation Of A Wholly Owned Subsidiary.Dec 24, 2025
Closure of Trading WindowDec 24, 2025
Disclosure Under Regulation 30(5)Dec 15, 2025
Intimation With Respect To Proposed Incorporation Of A Wholly Owned Subsidiary Is Enclosed HerewithDec 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementDec 15, 2025
Outcome Of The Board Meeting Held On December 15 2025Dec 15, 2025
Disclosure Under Regulation 30 Of SEBI LODR 2015 For Details Of Order Received From GST Authority Gujarat.Nov 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptOct 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 18, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 17, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Oct 17, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationOct 17, 2025
RPG Life Sciences Limited Has Submitted To The Exchange The Financial Results For The Quarter And Half Year Ended September 30 2025.Oct 17, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On October 17 2025Oct 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Board Meeting Intimation for Board Meeting Intimation For RPG Life Sciences Limited To Consider And Approve Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Oct 10, 2025

Mutual Fund Holdings

Technical Indicators

RSI(14)
Neutral
68.32
ATR(14)
Less Volatile
96.40
STOCH(9,6)
Overbought
82.66
STOCH RSI(14)
Neutral
72.58
MACD(12,26)
Bullish
40.97
ADX(14)
Strong Trend
40.40
UO(9)
Bearish
59.11
ROC(12)
Uptrend But Slowing Down
22.85
WillR(14)
Overbought
-19.39